Literature DB >> 34478331

Comparative study of CT and MRI appearances in mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma.

Dajun Lu1, Weibiao Yuan1, Qingqiang Zhu2, Jing Ye2, Wenrong Zhu2, Wenxin Chen2.   

Abstract

OBJECTIVE: To explore the feasibility of CT and MRI in differentiating mucinous tubular and spindle cell carcinoma (MTSCC) and papillary renal cell carcinoma (PRCC).
METHODS: 23 patients with MTSCC and 38 patients with PRCC were studied retrospectively. CT and MRI were undertaken to investigate differences in tumour characteristics.
RESULTS: 23 patients with MTSCC and 38 patients with PRCC (included 15 cases Type 1,and 23 cases Type 2), tumours (mean diameter 3.7 ± 1.6 cm vs 4.6 ± 1.7 cm, p < 0.05), cystic components (5 vs 32, p < 0.01), calcifications (3 vs 11, p > 0.05), haemorrhage (1 vs 22, p < 0.01), tumour boundaries (1 vs 37, p < 0.01), and homogeneous enhancement (20 vs 11, p < 0.01). The density of MTSCC was lower than that of PRCC, normal renal cortex (p < 0.05), except for the medulla(p > 0.05). MTSCC and PRCC tumour enhancement were lower than that for normal cortex and medulla during all enhanced phases (p < 0.05). Enhancement was higher with PRCC than with MTSCC tumours during all phases (p < 0.05). On MRI, nine cases of MTSCC and 19 cases of PRCC, tumour showed homogeneous (9 vs 3, p < 0.01), heterogeneous (0 vs 16, p < 0.01), hyperintense on T1WI (0 vs 15, p < 0.01), slightly hyperintense on T2WI (9 vs 1, p < 0.01), hypointense on T2WI (0 vs 15, p < 0.05) , relatively high signal intensity was seen on DWI (9 vs 15, p > 0.05), respectively.
CONCLUSION: CT imaging features of MTSCC include isodense or hypodense mass on unenhanced CT, with unclear boundaries; however, PRCC showed mild hyperdensity, easily have cystic components. The degree enhancement of MTSCC is lower than that for PRCC. On MR, MTSCC was slightly hyperintense on T2WI, whereas PRCC was hypointense. ADVANCES IN KNOWLEDGE: 1.CT imaging features of MTSCC include isodense or hypodense mass on unenhanced CT, with unclear boundaries.2. CT imaging features of PRCC include mild hyperdensity on unenhanced CT, easily have cystic components.3. On enhanced CT, the degree enhancement of MTSCC is lower than that for PRCC. On MR, MTSCC was slightly hyperintense on T2WI whereas PRCC was heterogeneously hypointense on T2WI.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34478331      PMCID: PMC9328054          DOI: 10.1259/bjr.20210548

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.629


  23 in total

1.  Papillary Renal Neoplasm With Reverse Polarity: A Morphologic, Immunohistochemical, and Molecular Study.

Authors:  Khaleel I Al-Obaidy; John N Eble; Liang Cheng; Sean R Williamson; Wael A Sakr; Nilesh Gupta; Muhammad T Idrees; David J Grignon
Journal:  Am J Surg Pathol       Date:  2019-08       Impact factor: 6.394

Review 2.  Papillary Renal Cell Carcinoma (PRCC): An Update.

Authors:  Mohammed Akhtar; Issam A Al-Bozom; Turki Al Hussain
Journal:  Adv Anat Pathol       Date:  2019-03       Impact factor: 3.875

3.  Unusual renal oncocytomas: pathologic and CT correlations.

Authors:  H Honda; S Bonsib; T J Barloon; K Masuda
Journal:  Urol Radiol       Date:  1992

4.  Distribution of Vascular Patterns in Different Subtypes of Renal Cell Carcinoma. A Morphometric Study in Two Distinct Types of Blood Vessels.

Authors:  Amparo Ruiz-Saurí; V García-Bustos; E Granero; S Cuesta; M A Sales; V Marcos; A Llombart-Bosch
Journal:  Pathol Oncol Res       Date:  2017-07-01       Impact factor: 3.201

5.  Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms.

Authors:  A K Avery; J Beckstead; A A Renshaw; C L Corless
Journal:  Am J Surg Pathol       Date:  2000-02       Impact factor: 6.394

6.  Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution.

Authors:  Gladell P Paner; John R Srigley; Anuradha Radhakrishnan; Cynthia Cohen; Brian F Skinnider; Satish K Tickoo; Andrew N Young; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2006-01       Impact factor: 6.394

7.  Renal Cell Carcinoma: Comparison between Variant Histology and Clear Cell Carcinoma across All Stages and Treatment Modalities.

Authors:  Marina Deuker; Franziska Stolzenbach; Giuseppe Rosiello; Carlotta Palumbo; Thomas Martin; Zhe Tian; Felix K-H Chun; Fred Saad; Shahrokh F Shariat; Anil Kapoor; Pierre I Karakiewicz
Journal:  J Urol       Date:  2020-04-06       Impact factor: 7.450

Review 8.  Clear cell papillary renal cell carcinoma: a review.

Authors:  Naoto Kuroda; Chisato Ohe; Fumi Kawakami; Shuji Mikami; Mitsuko Furuya; Keiko Matsuura; Masatsugu Moriyama; Yoji Nagashima; Ming Zhou; Fredrik Petersson; José I López; Ondrej Hes; Michal Michal; Mahul B Amin
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

9.  [Renal cell carcinoma diagnosis and prognosis within the context of the WHO classification 2016].

Authors:  A Zimpfer; Ä Glass; H Zettl; M Maruschke; O W Hakenberg; A Erbersdobler
Journal:  Urologe A       Date:  2019-09       Impact factor: 0.639

10.  Collecting duct carcinoma of the kidney: CT and pathologic correlation.

Authors:  Seong Kuk Yoon; Kyung Jin Nam; Seo-Hee Rha; Jeong Kon Kim; Kyoung-Sik Cho; Bohyun Kim; Kie Hwan Kim; Kyung-Ah Kim
Journal:  Eur J Radiol       Date:  2005-11-02       Impact factor: 3.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.